Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Disease × Rituximab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 271 Lymphoma, Large B-Cell, Diffuse 257 Leukemia, Lymphocytic, Chronic, B-Cell 189 Lymphoma, Non-Hodgkin 186 Lymphoma, Mantle-Cell 164 Lymphoma, Follicular 164 Lymphoma, B-Cell, Marginal Zone 114 Leukemia 94 Burkitt Lymphoma 82 Precursor Cell Lymphoblastic Leukemia-Lymphoma 79 Waldenstrom Macroglobulinemia 77 Lymphoma, B-Cell 61 Recurrence 50 Hodgkin Disease 50 Lymphoma, Large-Cell, Immunoblastic 44 Lymphoma, Large-Cell, Anaplastic 20 Leukemia, Myeloid, Acute 20 Myelodysplastic Syndromes 18 Intraocular Lymphoma 15 Hematologic Neoplasms 15 Neoplasms 14 Dendritic Cell Sarcoma, Interdigitating 14 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 13 Multiple Myeloma 13 Leukemia, Hairy Cell 13 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11 Neoplasms, Plasma Cell 10 Leukemia, Prolymphocytic 10 Lymphoma, T-Cell 9 Leukemia, Myelomonocytic, Chronic 9

Interventions

Blood Specimen Collection 9 Surveys and Questionnaires 5 Magnetic Resonance Spectroscopy 5 Biopsy 5 Prednisone 4 Colonoscopy 4 Biopsy, Fine-Needle 4 Tomography, X-Ray Computed 3 Surgical Procedures, Operative 3 Mammography 3 Magnetic Resonance Imaging 3 Liquid Biopsy 3 Lenalidomide 3 Interviews as Topic 3 Diagnostic Tests, Routine 3 Cyclophosphamide 3 weifuchun 2 pembrolizumab 2 obinutuzumab 2 Urination 2 Preoperative Exercise 2 Positron Emission Tomography Computed Tomography 2 Methods 2 Melphalan 2 Immunohistochemistry 2 Gemcitabine 2 Exercise 2 Educational Status 2 Doxorubicin 2 Dexamethasone 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01659099 2018-03-07

GAINED

The Lymphoma Academic Research Organisation

Phase 3 Terminated

Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡